Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dunhall Pharmaceuticals was a specialty pharmaceutical company based in Gravette, Arkansas, primarily focused on the nutritional and prenatal health markets. The company was most recognized for its proprietary iron supplement, Niferex, which became a leading brand for treating iron deficiency anemia. In addition to hematology products, Dunhall marketed a variety of prenatal vitamins and mineral supplements to healthcare professionals. In 2001, the company was acquired by KV Pharmaceutical for approximately $52 million and integrated into its Ther-Rx subsidiary. This acquisition allowed the parent company to expand its presence in the branded women's healthcare and nutritional supplement sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dunhall Pharmaceuticals.